Net-Net Security Gateway secures connections for nano3G femtocells and picocells
BEDFORD, MA, OCTOBER 3, 2011—Acme Packet® (NASDAQ:APKT), the leader in session delivery network solutions, today announced a new partnership with ip.access, a leading provider of picocell and femtocell infrastructure solutions. The companies will collaborate on small cell solutions and ip.access will integrate and support the Net-Net® Security Gateway to secure the ip.access nano3G small cell system.
Small cells, including femtocells and picocells, are indoor cellular base stations that extend the reach and improve the performance of mobile voice and data services. They are designed to improve the customer experience for consumer, enterprise and public space environments, while offloading the more costly macro radio and backhaul networks. The small cell architecture uses the Internet to connect the small cell access point to the mobile core network.
This new partnership integrates the Net-Net® Security Gateway as part of the ip.access nano3G femtocell and picocell solution. The Net-Net Security Gateway fulfills the security gateway functional requirements defined in the Third Generation Partnership Project (3GPP), providing authentication and IPsec tunnel management between the ip.access nano3G Access Points and the Access Controller. IPsec tunnels protect all subscriber voice and data traffic and the management packets from tampering, eavesdropping or interception. The two companies have worked together to enhance reliability, security and manageability of small cells. The turnkey solution has been tested and is deployed in live customer networks.
The Acme Packet Net-Net Security Gateway features several significant technical advantages that maximize capacity, minimize costs and assure service availability. It provides up to 200,000 IPsec tunnels with high-performance IPsec processing architecture in a single rack unit system, providing cost effective scalability as services expand. It features integrated hardware- and software-based DoS/DDoS attack protection and carrier-class high availability to protect the network and service up-time.
ip.access has more than 60 customers for its 3G and 2G small cell solutions, and its femtocell technology is deployed in more than 500,000 small cell access points in homes, offices and mobile network hotspots worldwide. Infonetics Research recently reported that ip.access has the leading market share of femtocell units deployed and ABI Research ranks the company as the leading picocell supplier in the world.
The nano3G femtocell and picocell solution is optimized for residential, enterprise and public hotspot deployments, supporting open access, bi-directional handover with the macro network and active alarms. The Access Controller scales from a few hundred access points to mass market residential volumes. Plug-and-play customer installation and IP backhaul make nano3G a highly cost-effective solution for coverage and capacity challenges, while full 3GPP standards compliance provides flexibility and interoperability with third party components.
“Service providers demand a comprehensive security solution in order to successfully deploy small cells,” said Dr. Andy Tiller, senior vice president of product strategy and marketing at ip.access. “We have partnered with Acme Packet as they provide a leading solution – the secure, scalable and robust Net-Net Security Gateway – and relevant experience fulfilling stringent IP service delivery requirements.”
“ip.access is a small cell market leader with a broad product portfolio for enterprise and consumer markets,” explained Mark Vella, vice president of business development with Acme Packet. “This partnership combines small cell authority with security expertise to create a compelling and cost-effective solution to meet current and future service provider needs.”
Acme Packet is a silver sponsor of the ip.access 5th User Group taking place October 2nd in Dubai, UAE and October 11th-12th in London, UK.
Headquartered in Cambridge, UK, ip.access Ltd (www.ipaccess.com) is a leading manufacturer of cost-effective picocell and femtocell infrastructure solutions for GSM, GPRS, EDGE and 3G. These solutions bring IP and cellular technologies together to drive down costs and increase coverage and capacity of mobile networks.
ABI Research ranks ip.access as the world’s number 1 picocell vendor; its nanoGSM® and nano3G™ picocell solutions provide 2G and 3G coverage and capacity for offices, shops and (using satellite backhaul) passenger aircraft, ships and remote rural areas. nanoGSM is the world’s most deployed picocell, with live installations in more than 50 networks around the world and growing. ip.access is also the company behind the multi-award winning Oyster 3G™ femtocell technology, which dramatically improves the user experience for 3G services at home. Oyster 3G is the core femtocell technology in AT&T’s 3G MicroCell.
ip.access counts Scottish Equity Partners, Rothschild Gestion, Intel Capital, Amadeus Capital Partners, Tyco Electronics, Cisco, Qualcomm and Motorola Ventures among its shareholders. For more information visit http://www.ipaccess.com/.
About Acme Packet
Acme Packet (NASDAQ: APKT), the leader in session delivery network solutions, enables the trusted, first-class delivery of next-generation voice, data and unified communications services and applications across IP networks. Our Net-Net product family fulfills demanding security, service assurance and regulatory requirements in service provider, enterprise and contact center networks. Based in Bedford, Massachusetts, Acme Packet designs and manufactures its products in the USA, selling them through over 150 reseller partners worldwide. More than 1,440 customers in 105 countries have deployed over 13,000 Acme Packet systems, including 90 of the top 100 service providers and 34 of the Fortune 100. For more information visit www.acmepacket.com.
Acme Packet Safe Harbor Statement
Statements contained herein that are not historical fact may be forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements may relate, among other things, to our position in the session border control market, our expected financial and operating results, our ability to establish and maintain intellectual property rights, our ability to build and grow Acme Packet, our potential next stage of growth, the benefits and advantages of our products, including any enhancements or new features, services and programs, and our ability to achieve our goals, plans and objectives. Such forward-looking statements do not constitute guarantees of future performance and are subject to a variety of risks and uncertainties that could cause our actual results to differ materially from those anticipated. These include, but are not limited to: difficulties in growing our customer base, difficulties leveraging market opportunities, difficulties providing solutions that meet the needs of customers, poor product sales, long sales cycles, difficulty developing new products, difficulty in relationships with vendors and partners, higher risk in international operations, difficulty managing rapid growth, and increased competition. Additional factors that could cause actual results to differ materially from those projected or suggested in any forward-looking statements are contained in our recent filings with the Securities and Exchange Commission, including those factors discussed under the caption “Risk Factors” in such filings.